🇺🇸 FDA
Pipeline program

DM199

DM199-2018-001

Phase 1 small_molecule completed

Quick answer

DM199 for Chronic Kidney Disease is a Phase 1 program (small_molecule) at DiaMedica Therapeutics with 1 ClinicalTrials.gov record(s).

Program details

Company
DiaMedica Therapeutics
Indication
Chronic Kidney Disease
Phase
Phase 1
Modality
small_molecule
Status
completed

Clinical trials